Common treatment can wake up dormant cancer cells, causing the disease to spread from original sites to other organs, team discovers.

This new article publication from Acta Pharmaceutica Sinica B, discusses how ALKBH3-regulated m1A of ALDOA potentiates ...

This new article publication from Acta Pharmaceutica Sinica B, discusses how ALKBH3-regulated m1A of ALDOA potentiates glycolysis and doxorubicin resistance of triple negative breast cancer cells.

This research indicates that Doxorubicin (Dox)-resistant TNBC cells exhibit increased glycolysis and ATP generation compared ...

One of the biggest obstacles in cancer treatment is drug resistance in cancer cells. Conventional efforts have focused on ...

China’s National Medical Products Administration gave the green light to Simcere Pharmaceutical Group Ltd.’s Enzeshu (suvemcitug) for treating recurrent ovarian cancer, fallopian tube cancer, or ...

The Company's aim is to seek FDA consent to fast track the Clinical Development Program to treat Basal Cell Carcinoma (BCC) of the skin using Dissolvable Doxorubicin-containing Microneedle Arrays ...

A new randomized, placebo-controlled clinical trial has found that short-term supplementation with CBD/CBDA-rich hemp oil appears safe and well-tolerated in dogs receiving chemotherapy for lymphoma.

The buyer in this case is Alembic’s US subsidiary, Alembic Pharmaceuticals Inc., which will take over full ownership of Utility.

In this HotCopper Capital Compass interview, Race Oncology (ASX:RAC) chairman Dr Pete Smith discusses the company’s “safe and successful” Phase One clinical trials and the RC220 plus doxorubicin ...

In this study, we designed a cell-penetrating gold nanoparticle platform to increase drug delivery to brain metastatic breast cancer cells. TAT peptide-modified gold nanoparticles carrying doxorubicin ...

Doxorubicin was able to penetrate the cell membranes and bind to the nucleic material (red fluorescence), although the T-cell receptors were blocked. No doxorubicin was detected in the lysosomes.